At Applied Biology our mission is to bring ideas to life that lead to life-changing therapies.


Clinical Studies
Lectures
Patents
Publications
FDA Applications
European Applications

News

News
  • Andy Goren, MD
  • ·
  • 28 November 2020

Dr. Andy Goren Presents COVID-19 Research to Brazil Minister of Science

Dr. Goren and Astronaut Marcos Pontes, State Minister of Science of Brazil, met to discuss anti-androgens as a treatment for COVID-19.

News
  • Andy Goren, MD
  • ·
  • 2019

History of Vitiligo

Kovacevic Maja, Franceschi Nika, Situm Mirna, Goren Andy, Stanimirovic Andrija, Valle Yan, Lotti Torello. Springer

  • Andy Goren, MD
  • ·
  • 15 March 2018

PHASE I STUDY COMPLETE

Topical Drug for the Treatment of FPHL in Non-responders to 5% Topical Minoxidil

WCHR CONGRESS
  • Andy Goren, MD
  • ·
  • 5 October 2017

WCHR CONGRESS

Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil

  • Andy Goren, MD
  • ·
  • 22 August 2017

EADV Congress

Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil

  • Andy Goren, MD
  • ·
  • 4 June 2017

NAHRS Congress

α1-AR Agonist Induced Piloerection Protects Against the Development of Traction Alopecia

  • John McCoy, PhD
  • ·
  • 4 May 2015

SID Congress

Novel Diagnostic Test Predicts Mean Change in Hair Counts in Female Androgenetic Alopecia Patients Treated with Topical Minoxidil

Applied Biology is a biotechnology company focusing on hair science. Our development of breakthrough drugs and medical devices for the treatment of hair disorders range from genetic markers to harnessing the power of the microbiome. These landmark developments have allowed us to innovate hair treatments for healthier lives. Our commitment extends beyond product innovation to ethical and sustainable medical practices.

© 2022 Applied Biology, s.r.o. All Rights Reserved.       Privacy Policy